Ceapro Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRPOF research report →
Companywww.ceapro.com
Ceapro Inc. , a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. It operates in two segments, Active Ingredient Product Technology Industry and Cosmeceutical Industry.
- CEO
- Gilles R. Gagnon
- IPO
- 2021
- HQ
- Edmonton, AB, CA
Price Chart
Valuation
- Market Cap
- $13.31M
- P/E
- -3.74
- P/S
- 0.07
- P/B
- 0.63
- EV/EBITDA
- 1.54
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 36.99%
- Op Margin
- -64.93%
- Net Margin
- -48.89%
- ROE
- -15.66%
- ROIC
- -16.57%
Growth & Income
- Revenue
- $9.63M · -48.87%
- Net Income
- $-4,709,893 · -207.09%
- EPS
- $-0.06 · -206.74%
- Op Income
- $-6,255,360
- FCF YoY
- -173.13%
Performance & Tape
- 52W High
- $0.40
- 52W Low
- $0.12
- 50D MA
- $0.18
- 200D MA
- $0.20
- Beta
- 1.38
- Avg Volume
- 6.12K
Get TickerSpark's AI analysis on CRPOF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CRPOF Coverage
We haven't published any research on CRPOF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CRPOF Report →